308 related articles for article (PubMed ID: 29413690)
1. The future of blood-based biomarkers for the early detection of breast cancer.
Loke SY; Lee ASG
Eur J Cancer; 2018 Mar; 92():54-68. PubMed ID: 29413690
[TBL] [Abstract][Full Text] [Related]
2. [Biomarkers for early screening and diagnosis of breast cancer: a review].
Liang Y; Hao M; Guo R; Li X; Li Y; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1425-1444. PubMed ID: 37154315
[TBL] [Abstract][Full Text] [Related]
3. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
4. Blood-based DNA methylation as biomarker for breast cancer: a systematic review.
Tang Q; Cheng J; Cao X; Surowy H; Burwinkel B
Clin Epigenetics; 2016; 8():115. PubMed ID: 27895805
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
[TBL] [Abstract][Full Text] [Related]
6. A new insight on serum microRNA expression as novel biomarkers in breast cancer patients.
Bahmanpour Z; Sheervalilou R; Choupani J; Shekari Khaniani M; Montazeri V; Mansoori Derakhshan S
J Cell Physiol; 2019 Nov; 234(11):19199-19211. PubMed ID: 31026062
[TBL] [Abstract][Full Text] [Related]
7. A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years.
Lourenco AP; Benson KL; Henderson MC; Silver M; Letsios E; Tran Q; Gordon KJ; Borman S; Corn C; Mulpuri R; Smith W; Alpers J; Costantini C; Rohatgi N; Yang R; Haythem A; Biren S; Morris M; Kass F; Reese DE
Clin Breast Cancer; 2017 Nov; 17(7):516-525.e6. PubMed ID: 28624156
[TBL] [Abstract][Full Text] [Related]
8. Biomarker Studies in Early Detection and Prognosis of Breast Cancer.
Li G; Hu J; Hu G
Adv Exp Med Biol; 2017; 1026():27-39. PubMed ID: 29282678
[TBL] [Abstract][Full Text] [Related]
9. Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management.
Zubor P; Kubatka P; Kajo K; Dankova Z; Polacek H; Bielik T; Kudela E; Samec M; Liskova A; Vlcakova D; Kulkovska T; Stastny I; Holubekova V; Bujnak J; Laucekova Z; Büsselberg D; Adamek M; Kuhn W; Danko J; Golubnitschaja O
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200461
[TBL] [Abstract][Full Text] [Related]
10. Crucial considerations for pipelines to validate circulating biomarkers for breast cancer.
Ewaisha R; Gawryletz CD; Anderson KS
Expert Rev Proteomics; 2016; 13(2):201-11. PubMed ID: 26653344
[TBL] [Abstract][Full Text] [Related]
11. Early detection of breast cancer: new biomarker tests on the horizon?
Jotwani AC; Gralow JR
Mol Diagn Ther; 2009 Dec; 13(6):349-57. PubMed ID: 19925032
[TBL] [Abstract][Full Text] [Related]
12. Detection and identification of serum protein peak at 6648 m/z as a novel indicator in breast cancer based on mass spectrometry.
Song D; Yue L; Zhan Y; Zhang J; Yan Z; Fan Y; Yang H; Zhang D; Liu Q; Xia Z; Qin P; Jia J; Yue M; Yu J; Zheng S; Yang F; Wang J
Discov Med; 2017 May; 23(128):283-294. PubMed ID: 28715644
[TBL] [Abstract][Full Text] [Related]
13. Decoding the usefulness of non-coding RNAs as breast cancer markers.
Amorim M; Salta S; Henrique R; Jerónimo C
J Transl Med; 2016 Sep; 14():265. PubMed ID: 27629831
[TBL] [Abstract][Full Text] [Related]
14. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
[TBL] [Abstract][Full Text] [Related]
15. Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer.
Henderson MC; Hollingsworth AB; Gordon K; Silver M; Mulpuri R; Letsios E; Reese DE
PLoS One; 2016; 11(8):e0157692. PubMed ID: 27508384
[TBL] [Abstract][Full Text] [Related]
16. The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer.
Lee YJ; Kim Y; Choi BB; Kim JR; Ko HM; Suh KH; Lee JS
BMC Cancer; 2022 Jan; 22(1):12. PubMed ID: 34979986
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
[TBL] [Abstract][Full Text] [Related]
18. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
[TBL] [Abstract][Full Text] [Related]
19. The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol.
Giordano L; Gallo F; Petracci E; Chiorino G; Segnan N;
BMC Cancer; 2017 Nov; 17(1):785. PubMed ID: 29166878
[TBL] [Abstract][Full Text] [Related]
20. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]